ESR1 and breast carcinoma: African-American patients have a greater incidence of breast cancer between 30 and 44 years (which is less likely to be screen-detected) and their tumors are more likely to be poorly differentiated and estrogen receptor (ER) negative, with high nuclear atypia and higher S-phase fraction 4.